Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-06 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 5e-05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |